153 related articles for article (PubMed ID: 11587796)
1. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity.
Tsubery H; Ofek I; Cohen S; Fridkin M
Peptides; 2001 Oct; 22(10):1675-81. PubMed ID: 11587796
[TBL] [Abstract][Full Text] [Related]
2. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.
Tsubery H; Ofek I; Cohen S; Fridkin M
J Med Chem; 2000 Aug; 43(16):3085-92. PubMed ID: 10956216
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization.
Tsubery H; Ofek I; Cohen S; Eisenstein M; Fridkin M
Mol Pharmacol; 2002 Nov; 62(5):1036-42. PubMed ID: 12391265
[TBL] [Abstract][Full Text] [Related]
4. Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters.
Kim SJ; Jo J; Kim J; Ko KS; Lee W
Microbiol Spectr; 2024 Apr; 12(4):e0368723. PubMed ID: 38391225
[TBL] [Abstract][Full Text] [Related]
5. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide.
Tsubery H; Ofek I; Cohen S; Fridkin M
Biochemistry; 2000 Oct; 39(39):11837-44. PubMed ID: 11009595
[TBL] [Abstract][Full Text] [Related]
6. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria.
Tsubery H; Yaakov H; Cohen S; Giterman T; Matityahou A; Fridkin M; Ofek I
Antimicrob Agents Chemother; 2005 Aug; 49(8):3122-8. PubMed ID: 16048913
[TBL] [Abstract][Full Text] [Related]
7. Role of the cell envelope in the antibacterial activities of polymyxin B and polymyxin B nonapeptide against Escherichia coli.
Sahalan AZ; Dixon RA
Int J Antimicrob Agents; 2008 Mar; 31(3):224-7. PubMed ID: 18083010
[TBL] [Abstract][Full Text] [Related]
8. Novel des-fatty acyl-polymyxin B derivatives with Pseudomonas aeruginosa-specific antimicrobial activity.
Sato Y; Shindo M; Sakura N; Uchida Y; Kato I
Chem Pharm Bull (Tokyo); 2011; 59(5):597-602. PubMed ID: 21532197
[TBL] [Abstract][Full Text] [Related]
9. Lipid binding and membrane penetration of polymyxin B derivatives studied in a biomimetic vesicle system.
Katz M; Tsubery H; Kolusheva S; Shames A; Fridkin M; Jelinek R
Biochem J; 2003 Oct; 375(Pt 2):405-13. PubMed ID: 12848621
[TBL] [Abstract][Full Text] [Related]
10. Contribution of each amino acid residue in polymyxin B(3) to antimicrobial and lipopolysaccharide binding activity.
Kanazawa K; Sato Y; Ohki K; Okimura K; Uchida Y; Shindo M; Sakura N
Chem Pharm Bull (Tokyo); 2009 Mar; 57(3):240-4. PubMed ID: 19252313
[TBL] [Abstract][Full Text] [Related]
11. Binding of polymyxin B nonapeptide to gram-negative bacteria.
Vaara M; Viljanen P
Antimicrob Agents Chemother; 1985 Apr; 27(4):548-54. PubMed ID: 2988430
[TBL] [Abstract][Full Text] [Related]
12. Modulation of P2X7 receptor functions by polymyxin B: crucial role of the hydrophobic tail of the antibiotic molecule.
Ferrari D; Pizzirani C; Gulinelli S; Callegari G; Chiozzi P; Idzko M; Panther E; Di Virgilio F
Br J Pharmacol; 2007 Feb; 150(4):445-54. PubMed ID: 17211459
[TBL] [Abstract][Full Text] [Related]
13. Targeting lipopolysaccharides by the nontoxic polymyxin B nonapeptide sensitizes resistant Escherichia coli to the bactericidal effect of human neutrophils.
Rose F; Heuer KU; Sibelius U; Hombach-Klonisch S; Kiss L; Seeger W; Grimminger F
J Infect Dis; 2000 Jul; 182(1):191-9. PubMed ID: 10882597
[TBL] [Abstract][Full Text] [Related]
14. Development of des-fatty acyl-polymyxin B decapeptide analogs with Pseudomonas aeruginosa-specific antimicrobial activity.
Katsuma N; Sato Y; Ohki K; Okimura K; Ohnishi K; Sakura N
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):332-6. PubMed ID: 19336926
[TBL] [Abstract][Full Text] [Related]
15. The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.
Vaara M
Drugs Exp Clin Res; 1991; 17(9):437-43. PubMed ID: 1822436
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice.
Ofek I; Cohen S; Rahmani R; Kabha K; Tamarkin D; Herzig Y; Rubinstein E
Antimicrob Agents Chemother; 1994 Feb; 38(2):374-7. PubMed ID: 8192470
[TBL] [Abstract][Full Text] [Related]
17. Polymyxin B octapeptide and polymyxin B heptapeptide are potent outer membrane permeability-increasing agents.
Kimura Y; Matsunaga H; Vaara M
J Antibiot (Tokyo); 1992 May; 45(5):742-9. PubMed ID: 1624376
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides.
Urakawa H; Yamada K; Komagoe K; Ando S; Oku H; Katsu T; Matsuo I
Bioorg Med Chem Lett; 2010 Mar; 20(5):1771-5. PubMed ID: 20138759
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide binding and antibacterial activities of a synthetic peptide representing amino acids 90-101 of bactericidal/permeability-increasing protein.
Yeh TM; Chao SC; Chang HC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Aug; 27(3):120-32. PubMed ID: 9747342
[TBL] [Abstract][Full Text] [Related]
20. Effects of polymyxin B nonapeptide on Aeromonas salmonicida.
McCashion RN; Lynch WH
Antimicrob Agents Chemother; 1987 Sep; 31(9):1414-9. PubMed ID: 2823698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
